These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 24874735)
1. Elf3 drives β-catenin transactivation and associates with poor prognosis in colorectal cancer. Wang JL; Chen ZF; Chen HM; Wang MY; Kong X; Wang YC; Sun TT; Hong J; Zou W; Xu J; Fang JY Cell Death Dis; 2014 May; 5(5):e1263. PubMed ID: 24874735 [TBL] [Abstract][Full Text] [Related]
2. Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice. Peng K; Kou L; Yu L; Bai C; Li M; Mo P; Li W; Yu C Gastroenterology; 2019 Mar; 156(4):1112-1126. PubMed ID: 30472235 [TBL] [Abstract][Full Text] [Related]
3. ELF3 is an antagonist of oncogenic-signalling-induced expression of EMT-TF ZEB1. Liu D; Skomorovska Y; Song J; Bowler E; Harris R; Ravasz M; Bai S; Ayati M; Tamai K; Koyuturk M; Yuan X; Wang Z; Wang Y; Ewing RM Cancer Biol Ther; 2019; 20(1):90-100. PubMed ID: 30148686 [No Abstract] [Full Text] [Related]
4. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis. Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932 [TBL] [Abstract][Full Text] [Related]
5. ELF3 promotes epithelial-mesenchymal transition by protecting ZEB1 from miR-141-3p-mediated silencing in hepatocellular carcinoma. Zheng L; Xu M; Xu J; Wu K; Fang Q; Liang Y; Zhou S; Cen D; Ji L; Han W; Cai X Cell Death Dis; 2018 Mar; 9(3):387. PubMed ID: 29523781 [TBL] [Abstract][Full Text] [Related]
6. MNX1 promotes cell proliferation and activates Wnt/β-catenin signaling in colorectal cancer. Yang X; Pan Q; Lu Y; Jiang X; Zhang S; Wu J Cell Biol Int; 2019 Apr; 43(4):402-408. PubMed ID: 30614606 [TBL] [Abstract][Full Text] [Related]
8. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression. Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398 [TBL] [Abstract][Full Text] [Related]
9. Involvement of splicing factor-1 in beta-catenin/T-cell factor-4-mediated gene transactivation and pre-mRNA splicing. Shitashige M; Naishiro Y; Idogawa M; Honda K; Ono M; Hirohashi S; Yamada T Gastroenterology; 2007 Mar; 132(3):1039-54. PubMed ID: 17383426 [TBL] [Abstract][Full Text] [Related]
10. Histone demethylase JMJD1A promotes colorectal cancer growth and metastasis by enhancing Wnt/β-catenin signaling. Peng K; Su G; Ji J; Yang X; Miao M; Mo P; Li M; Xu J; Li W; Yu C J Biol Chem; 2018 Jul; 293(27):10606-10619. PubMed ID: 29802196 [TBL] [Abstract][Full Text] [Related]
11. ETS transcription factor ESE1/ELF3 orchestrates a positive feedback loop that constitutively activates NF-κB and drives prostate cancer progression. Longoni N; Sarti M; Albino D; Civenni G; Malek A; Ortelli E; Pinton S; Mello-Grand M; Ostano P; D'Ambrosio G; Sessa F; Garcia-Escudero R; Thalmann GN; Chiorino G; Catapano CV; Carbone GM Cancer Res; 2013 Jul; 73(14):4533-47. PubMed ID: 23687337 [TBL] [Abstract][Full Text] [Related]
12. TTPAL Promotes Colorectal Tumorigenesis by Stabilizing TRIP6 to Activate Wnt/β-Catenin Signaling. Gou H; Liang JQ; Zhang L; Chen H; Zhang Y; Li R; Wang X; Ji J; Tong JH; To KF; Sung JJY; Chan FKL; Fang JY; Yu J Cancer Res; 2019 Jul; 79(13):3332-3346. PubMed ID: 31018940 [TBL] [Abstract][Full Text] [Related]
13. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells. Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031 [TBL] [Abstract][Full Text] [Related]
14. Expression of CD44 is regulated by ELF3 in 5-FU treated colorectal cancer cells. Li F; Qiu F; Fan X; Yu Q; Liu S; Guo Y; Zhu Y; Xi X; Du B Gene; 2024 Jan; 892():147896. PubMed ID: 37832805 [TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic SHMT2 drives the progression and metastasis of colorectal cancer by inhibiting β-catenin degradation. Liu C; Wang L; Liu X; Tan Y; Tao L; Xiao Y; Deng P; Wang H; Deng Q; Lin Y; Jie H; Zhang H; Zhang J; Peng Y; Zhang H; Zhou Z; Sun Q; Cen X; Zhao Y Theranostics; 2021; 11(6):2966-2986. PubMed ID: 33456583 [No Abstract] [Full Text] [Related]
16. A transcriptional repressive role for epithelial-specific ETS factor ELF3 on oestrogen receptor alpha in breast cancer cells. Gajulapalli VN; Samanthapudi VS; Pulaganti M; Khumukcham SS; Malisetty VL; Guruprasad L; Chitta SK; Manavathi B Biochem J; 2016 Apr; 473(8):1047-61. PubMed ID: 26920025 [TBL] [Abstract][Full Text] [Related]
17. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling. Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of ELF3 facilitates cell growth and metastasis through PI3K/Akt and ERK signaling pathways in non-small cell lung cancer. Wang H; Yu Z; Huo S; Chen Z; Ou Z; Mai J; Ding S; Zhang J Int J Biochem Cell Biol; 2018 Jan; 94():98-106. PubMed ID: 29208568 [TBL] [Abstract][Full Text] [Related]
19. RUNX1 promotes tumour metastasis by activating the Wnt/β-catenin signalling pathway and EMT in colorectal cancer. Li Q; Lai Q; He C; Fang Y; Yan Q; Zhang Y; Wang X; Gu C; Wang Y; Ye L; Han L; Lin X; Chen J; Cai J; Li A; Liu S J Exp Clin Cancer Res; 2019 Aug; 38(1):334. PubMed ID: 31370857 [TBL] [Abstract][Full Text] [Related]
20. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors. Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]